All posts by: Michael Zand

About Michael Zand

CAR T-cell therapies in treating lymphoma: Pros and cons – ModernMedicine

Continue reading

2017-12-26 NEWS

CAR T-cell therapies in treating lymphoma: Pros and cons
ModernMedicine
Catherine Bollard, MD, director of the Center for Cancer and Immunology Research at Washington, D.C.-based Children’s National Health System, discussed immunotherapy for non-Hodgkin’s lymphoma at the 2017 American Society of Hematology (ASH) annual

Continue reading

2017-12-26 NEWS

Medical News Bulletin

Cancer Immunotherapy Treatment Hits a Hurdle
Medical News Bulletin
Cancer immunotherapy has recently seen some great advancements and a lot of hope lies in this treatment approach. Cancer immunotherapy is a type of therapy approach that uses the body’s own immune system to target and fight off cancer. This type of
Immunotherapy: The next frontier in cancer treatment | afr.comThe Australian Financial Review

all 2 news articles »

Continue reading

2017-12-26 NEWS

WIRED

Crispr Isn’t Enough Any More. Get Ready for Gene Editing 2.0
WIRED
In fewer than five years, the gene-editing technology known as Crispr has revolutionized the face and pace of modern biology. Since its ability to find, remove, and replace genetic material was first reported in 2012, scientists have published more
Bioethicist discusses possibilities, pitfalls of gene editingDuluth News Tribune

all 2 news articles »

Continue reading

2017-12-26 NEWS

The Australian Financial Review

Immunotherapy: The next frontier in cancer treatment
The Australian Financial Review
This is where immunotherapy started and, while scientists have been trying to work out where it fits, it has been leapfrogging forward and is now used as a first-line treatment for melanoma and a second line for lung, bladder and kidney cancer. It’s
Thousands given hope in cancer care revolutionThe Times

all 1 news articles »

Continue reading

2017-12-26 NEWS

The Australian Financial Review

Immunotherapy: The next frontier in cancer treatment
The Australian Financial Review
This is where immunotherapy started and, while scientists have been trying to work out where it fits, it has been leapfrogging forward and is now used as a first-line treatment for melanoma and a second line for lung, bladder and kidney cancer. It’s
Thousands given hope in cancer care revolutionThe Times

all 1 news articles »